Seattle, Washington (PRWEB) March 14, 2013
MCG today announced the release of a new product designed to help hospital case managers link care decisions to the latest clinical findings.
Indicia for Case Management is the newest addition to Indicia, MCG’s product line created to help hospitals and other healthcare providers deliver effective care.
“From traditional fee-for-service to the new bundled payments, hospitals face a shifting set of reimbursement models,” said Dr. Nick Beard, MCG’s senior vice president of product management. “What remains constant is the need to make decisions based on the best evidence and focused on optimal patient outcomes.”
Indicia for Case Management – interactive software tailored to the workflow of case managers in a hospital setting – is designed to support efficient documentation of medical necessity using the most current clinical research. To this end, the product is being released in conjunction with a substantially updated edition of MCG’s care guidelines.
“Using our interactive software, hospitals can unlock the full value of the care guidelines,” said Dr. Beard. “For example, many hospitals are focused on reducing 30-day readmissions for conditions such as heart failure and community-acquired pneumonia. In response, we’ve increased our readmissions guidance tenfold for the 17th edition of the care guidelines. Based on patient data and prior clinical decisions tracked in Indicia for Case Management, users can identify patients at risk for readmissions and flag them for extra attention and care planning to reduce that risk.”
Indicia for Case Management enables hospital case managers to review and document admission, level of care, and length of stay decisions. A director of case management can filter by caseload to easily review the work of multiple case managers. Hospital executives can use the product’s robust reporting to identify gaps in care, capture variances, and uncover opportunities for improvement. Reporting features enable organizations to analyze performance against goal lengths of stay derived from the medical literature and checked against claims datasets.
Indicia for Utilization Review – another healthcare provider product – has been updated for 2013 and released in tandem with the 17th edition of the care guidelines. Indicia for Utilization Review is designed for hospitals that need quick access to up-to-date clinical evidence, but don’t require fully interactive support for case management.
MCG, formerly Milliman Care Guidelines, independently develops and produces evidence-based clinical guidelines and software used by more than 2,200 clients, including 1,200 hospitals and seven of the eight largest U.S. health plans. Updated annually by an experienced team of clinicians, the care guidelines support the care management of a majority of Americans. For more information, visit http://www.careguidelines.com